Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies

MLA

Rickles, Richard J., et al. “Adenosine A2A Receptor Agonists and PDE Inhibitors: A Synergistic Multitarget Mechanism Discovered through Systematic Combination Screening in B-Cell Malignancies.” Blood, vol. 116, no. 4, July 2010, pp. 593–602. EBSCOhost, https://doi.org/10.1182/blood-2009-11-252668.

APA

Rickles, R. J., Pierce, L. T., Giordano, T. P., Tam, W. F., McMillin, D. W., Delmore, J., Laubach, J. P., Borisy, A. A., Richardson, P. G., & Lee, M. S. (2010). Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies. Blood, 116(4), 593–602. https://doi.org/10.1182/blood-2009-11-252668

Chicago

Rickles, Richard J., Laura T. Pierce, Thomas P. Giordano, Winnie F. Tam, Douglas W. McMillin, Jake Delmore, Jacob P. Laubach, Alexis A. Borisy, Paul G. Richardson, and Margaret S. Lee. 2010. “Adenosine A2A Receptor Agonists and PDE Inhibitors: A Synergistic Multitarget Mechanism Discovered through Systematic Combination Screening in B-Cell Malignancies.” Blood 116 (4): 593–602. doi:10.1182/blood-2009-11-252668.